MedTrace Logo

Clinical Trial to Evaluate the Safety and Efficacy of MeRT Treatment in Post-Traumatic Stress Disorder

NCT02990793 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 158

Last updated 2026-01-15

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and efficacy of individualized, Biometrics-guided Magnetic e-Resonance Therapy (MeRT) treatment of Post-Traumatic Stress Disorder

Conditions

Interventions

DEVICE

Active MeRT Treatment

A personalized biometrics-guided protocol known as magnetic EEG/ECG resonance therapy (MeRT) treatment that is tailored specifically to each participant's EEG intrinsic alpha frequency (IAF). rTMS is applied at the participant's IAF.

DEVICE

Sham MeRT Treatment

rTMS coil does not emit magnetic stimulation.

Sponsors & Collaborators

  • Texas A&M University

    collaborator OTHER

  • GilpinPhillips BIOMED, LLC

    collaborator UNKNOWN

  • Peachtree BioResearch Solutions

    collaborator UNKNOWN

  • Wave Neuroscience

    lead INDUSTRY

Principal Investigators

  • Kenneth Ramos, MD,PhD · Texas A&M University

  • Adele Gilpin, PhD,JD · GilpinPhillips BIOMED, LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-04
Primary Completion
2025-09-18
Completion
2025-11-04
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02990793 on ClinicalTrials.gov